GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kontafarma China Holdings Ltd (HKSE:01312) » Definitions » Gross Margin %

Kontafarma China Holdings (HKSE:01312) Gross Margin % : 59.20% (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Kontafarma China Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Kontafarma China Holdings's Gross Profit for the six months ended in Dec. 2023 was HK$224.0 Mil. Kontafarma China Holdings's Revenue for the six months ended in Dec. 2023 was HK$378.4 Mil. Therefore, Kontafarma China Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 59.20%.


The historical rank and industry rank for Kontafarma China Holdings's Gross Margin % or its related term are showing as below:

HKSE:01312' s Gross Margin % Range Over the Past 10 Years
Min: 5.2   Med: 38.11   Max: 58.25
Current: 58.25


During the past 13 years, the highest Gross Margin % of Kontafarma China Holdings was 58.25%. The lowest was 5.20%. And the median was 38.11%.

HKSE:01312's Gross Margin % is ranked better than
69.81% of 987 companies
in the Drug Manufacturers industry
Industry Median: 46.47 vs HKSE:01312: 58.25

Kontafarma China Holdings had a gross margin of 59.20% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Kontafarma China Holdings was 11.80% per year.


Kontafarma China Holdings Gross Margin % Historical Data

The historical data trend for Kontafarma China Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kontafarma China Holdings Gross Margin % Chart

Kontafarma China Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.01 55.07 49.32 56.62 58.25

Kontafarma China Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.62 59.30 53.90 57.41 59.20

Competitive Comparison of Kontafarma China Holdings's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Kontafarma China Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kontafarma China Holdings's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kontafarma China Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Kontafarma China Holdings's Gross Margin % falls into.



Kontafarma China Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Kontafarma China Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=471.3 / 809.107
=(Revenue - Cost of Goods Sold) / Revenue
=(809.107 - 337.815) / 809.107
=58.25 %

Kontafarma China Holdings's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=224 / 378.402
=(Revenue - Cost of Goods Sold) / Revenue
=(378.402 - 154.388) / 378.402
=59.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Kontafarma China Holdings  (HKSE:01312) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Kontafarma China Holdings had a gross margin of 59.20% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Kontafarma China Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Kontafarma China Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kontafarma China Holdings (HKSE:01312) Business Description

Traded in Other Exchanges
N/A
Address
30 Harbour Road, Room 12A 09-20, 12th Floor, Sun Hung Kai Centre, Wanchai, Hong Kong, HKG
Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs and traditional Chinese medicine in the PRC, and the operation of fitness centers, provision of fitness and health consulting services, and the operation of franchises. The operating segments include pharmaceutical business and Fitness business. Majority of its revenue derives from pharmaceutical business segment.

Kontafarma China Holdings (HKSE:01312) Headlines

No Headlines